A Pilot Study of an mHealth Application for Healthcare Workers: Poor Uptake Despite High Reported Acceptability at a Rural South African Community-Based MDR-TB Treatment Program
暂无分享,去创建一个
Krisda H. Chaiyachati | Jessica E. Haberer | S. Cinti | Neal Lesh | J. Haberer | G. Friedland | Marian Loveday | Stephen Lorenz | Neal Lesh | Lee-Megan Larkan | Sandro Cinti | Gerald H. Friedland | K. Chaiyachati | M. Loveday | S. Lorenz | Lee-Megan Larkan
[1] Richard J. Holden,et al. The Technology Acceptance Model: Its past and its future in health care , 2010, J. Biomed. Informatics.
[2] Shaun Treweek,et al. Making trials matter: pragmatic and explanatory trials and the problem of applicability , 2009, Trials.
[3] W. Jack,et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial , 2010, The Lancet.
[4] U. Lalloo,et al. Culture Conversion Among HIV Co-Infected Multidrug-Resistant Tuberculosis Patients in Tugela Ferry, South Africa , 2011, PloS one.
[5] V. Zweigenthal,et al. TB and HIV integration: obstacles and possible solutions to implementation in South Africa , 2011, Tropical medicine & international health : TM & IH.
[6] D. Stryer,et al. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. , 2003, JAMA.
[7] G. Friedland,et al. Decentralised management of drug-resistant tuberculosis (MDR- and XDR-TB) in South Africa: an alternative model of care. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[8] A. Wu,et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. , 2004, Psychosomatics.
[9] G. Sotgiu,et al. Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India , 2012, PloS one.
[10] K. Wallengren,et al. Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[11] A. Gadkari,et al. The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy: A systematic review and meta-analysis , 2012, AIDS care.
[12] A. D. de Bont,et al. The contribution of qualitative research to the development of tailor-made community-based interventions in primary care: a review. , 2010, European journal of public health.
[13] M. Heo,et al. Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[14] Robert W Snow,et al. The effect of mobile phone text-message reminders on Kenyan health workers' adherence to malaria treatment guidelines: a cluster randomised trial , 2011, The Lancet.
[15] A. Wu,et al. Self‐Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection , 2001, Journal of acquired immune deficiency syndromes.
[16] Miguel P Caldas,et al. Research design: qualitative, quantitative, and mixed methods approaches , 2003 .
[17] J. Andrews,et al. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. , 2010, American journal of respiratory and critical care medicine.
[18] L. Thomson,et al. A health systems assessment of the KwaZulu-Natal tuberculosis programme in the context of increasing drug resistance. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[19] A. Wu,et al. Depression Is a Risk Factor for Suboptimal Adherence to Highly Active Antiretroviral Therapy , 2002, Journal of acquired immune deficiency syndromes.
[20] Shaun Treweek,et al. What kind of randomized trials do we need? , 2009, Journal of clinical epidemiology.
[21] Sonya S. Shin,et al. Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia. , 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[22] J. Hoffman,et al. Mobile direct observation treatment for tuberculosis patients: a technical feasibility pilot using mobile phones in Nairobi, Kenya. , 2010, American journal of preventive medicine.
[23] M. Chopra,et al. Improving the coverage of the PMTCT programme through a participatory quality improvement intervention in South Africa , 2009, BMC public health.
[24] Steven J. Reynolds,et al. Impact of a mHealth Intervention for Peer Health Workers on AIDS Care in Rural Uganda: A Mixed Methods Evaluation of a Cluster-Randomized Trial , 2011, AIDS and Behavior.
[25] U. Lalloo,et al. Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[26] Richard Birtwhistle,et al. Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity. , 2003, BMC medical research methodology.
[27] Tapan S. Parikh,et al. Mobile phone tools for field-based health care workers in low-income countries. , 2011, The Mount Sinai journal of medicine, New York.
[28] Ira B. Wilson,et al. Challenges in Using Mobile Phones for Collection of Antiretroviral Therapy Adherence Data in a Resource-Limited Setting , 2010, AIDS and Behavior.